These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29115187)

  • 21. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
    Cupp ME; Nayak SK; Adem AS; Thomsen WJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.
    Li H; Zhou Q; Bai BL; Weng SJ; Wu ZY; Xie ZJ; Feng ZH; Cheng L; Boodhun V; Yang L
    J Bone Miner Metab; 2018 Nov; 36(6):691-699. PubMed ID: 29280077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A salt bridge between Arg-20 on parathyroid hormone (PTH) and Asp-137 on the PTH1 receptor is essential for full affinity.
    Weaver RE; Wigglesworth MJ; Donnelly D
    Peptides; 2014 Nov; 61():83-7. PubMed ID: 25218037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein in the rat.
    Schetz JA; Mayr CA; Taylor JE; Rosenblatt M; Chorev M; Davis TP
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1456-62. PubMed ID: 7562522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.
    Yang Y; Aghazadeh-Habashi A; Panahifar A; Wu Y; Bhandari KH; Doschak MR
    Drug Deliv Transl Res; 2017 Aug; 7(4):482-496. PubMed ID: 28721611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation.
    El-Refaie WM; Elnaggar YS; El-Massik MA; Abdallah OY
    Pharm Res; 2015 Sep; 32(9):2901-11. PubMed ID: 25777613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronate-Peanut Agglutinin Conjugates for Target-Specific Bioimaging of Colon Cancer.
    Beack S; Cho M; Kim YE; Ahn GO; Hahn SK
    Bioconjug Chem; 2017 May; 28(5):1434-1442. PubMed ID: 28345902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer.
    DJung HS; Kong WH; Sung DK; Lee MY; Beack SE; Keum DH; Kim KS; Yun SH; Hahn SK
    ACS Nano; 2014 Jan; 8(1):260-8. PubMed ID: 24383990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
    Yue Y; Zhao D; Yin Q
    Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a Long-Acting Parathyroid Hormone 1-34 Analogue to Treat Hypoparathyroidism.
    Ruan S; Yang G; Dong Y; Shangguan W; Lu W
    Mol Pharm; 2021 Sep; 18(9):3260-3271. PubMed ID: 34482698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effects of hyaluronate - epidermal growth factor conjugate patch on chronic wound healing.
    Kim YS; Sung DK; Kong WH; Kim H; Hahn SK
    Biomater Sci; 2018 May; 6(5):1020-1030. PubMed ID: 29616250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
    Slovik DM; Rosenthal DI; Doppelt SH; Potts JT; Daly MA; Campbell JA; Neer RM
    J Bone Miner Res; 1986 Aug; 1(4):377-81. PubMed ID: 3503551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Flt1 peptide - hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy.
    Oh EJ; Choi JS; Kim H; Joo CK; Hahn SK
    Biomaterials; 2011 Apr; 32(11):3115-23. PubMed ID: 21277020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery.
    Xie J; Ji Y; Xue W; Ma D; Hu Y
    Colloids Surf B Biointerfaces; 2018 Dec; 172():323-329. PubMed ID: 30176512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues.
    Tsomaia N; Pellegrini M; Hyde K; Gardella TJ; Mierke DF
    Biochemistry; 2004 Jan; 43(3):690-9. PubMed ID: 14730973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the physical and biological properties of hyaluronan and hyaluronan fragments.
    Ferguson EL; Roberts JL; Moseley R; Griffiths PC; Thomas DW
    Int J Pharm; 2011 Nov; 420(1):84-92. PubMed ID: 21884772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
    Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological effects of a recombinant hPTH(1-34) derived peptide on ovariectomized rats.
    Chunxiao W; Chengying G; Liang J; Xiaoming S; Feng G; Junting Y; Wenhui W; Yu W; Jingjing L
    Eur J Pharmacol; 2017 Jan; 794():193-200. PubMed ID: 27887949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flt1 peptide-hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization.
    Kim H; Choi JS; Kim KS; Yang JA; Joo CK; Hahn SK
    Acta Biomater; 2012 Nov; 8(11):3932-40. PubMed ID: 22824530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.